Navigation Links
Gen-Probe Announces Webcasts of Three Upcoming Investor Events
Date:10/13/2008

- Third Quarter 2008 Earnings Conference Call on October 30 -

- Presentation at Oppenheimer's 19th Annual Healthcare Conference on

November 4 - - Annual Analyst Day for Institutional Investors and Financial Analysts on

November 7 -

SAN DIEGO, Oct. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will webcast three upcoming investor events.

First, Gen-Probe will release its third quarter 2008 financial results on Thursday, October 30, 2008 at approximately 4:00 pm Eastern Time (ET), followed by a conference call with management at 4:30 pm ET. The conference call will be webcast live and may be accessed on the investors section of the Company's web site at http://www.gen-probe.com. An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 866-505-9257 (US) or 203-369-1881 (international).

Second, the Company will present at Oppenheimer's 19th Annual Healthcare Conference in New York on Tuesday, November 4, 2008 at 12:40 pm ET. The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website. The webcast will be available for 30 days following the event.

Third, Gen-Probe will webcast its annual meeting with institutional investors and sell-side analysts in San Diego on Friday, November 7, 2008, at 8 am Pacific Time (11 am ET). The meeting, which will feature presentations on Gen-Probe's current business and future growth strategies, will conclude at approximately 11 am Pacific Time (2 pm ET). Institutional investors and sell-side analysts can RSVP to attend in person by contacting Paula Izidoro at paulai@gen-probe.com. Please note the new date and time. Others may access a live webcast through a link on the investors section of Gen-Probe's website. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended June 30, 2008, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro

Investor Relations

858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
3. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
4. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
5. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
6. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
7. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
8. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
9. Texas Back Institute Announces Nine for Your Spine for National Spine Health Day - October 16
10. CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
11. RF Technologies(R) Announces Code Alert(R) Integrated Care Management Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... in intellectual property (IP) to its specialty academic programs. , Answering to the ... college’s existing certificate programs in health law, and environmental and land use law. ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... in military battle for the country. The nonprofit Hope For Heroes partnered with ... that empower independence for disabled military veterans, as well as police, firemen, and EMS ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... , ... May 26, 2016 , ... MadgeTech will be ... engineered, and manufactured in Warner, New Hampshire at the MadgeTech headquarters. With products sold ... monitoring solutions trusted by government agencies, including NASA. , In 2012, NASA strategically ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Cirujanos holandeses han puesto en ... médicos a compartir sus mejores prácticas por el mundo ... médicos de Europa, África, Asia ... aplicación, que combina la transmisión en vivo con mensajería ... Educación   "Imagine un médico de Medicines ...
(Date:5/24/2016)... 24, 2016   , ... in overall bowel cleansing and superiority in ... leansing of the ascending ... , Norgine B.V. today announced new positive data from ... ascorbate bowel preparation) versus standard 2 litre PEG with ascorbate. The ...
(Date:5/24/2016)... -- ARANZ Medical  Ltd a specialist in ... been named the Coretex Hi-Tech Emerging Company of the Year ... Bruce Davey , CEO of ARANZ Medical says, "This ... to be recognised for the work we are doing to ... 35 countries around the world from Sub-Saharan Africa through to ...
Breaking Medicine Technology: